Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I and Pharmacologic Study of the Proteasome Inhibitor PS-341 in Patients With Advanced Solid Tumors and B-cell Lymphoproliferative Disorders

NCT00006362 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00006362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I and Pharmacologic Study of the Proteasome Inhibitor PS-341 in Patients With Advanced Solid Tumors and B-cell Lymphoproliferative Disorders
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
November 30, 1999
Completion date
August 31, 2003
Enrollment
Not reported
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, lymphoma, multiple myeloma and plasma cell neoplasm, precancerous condition, unspecified adult solid tumor, protocol specific